A service of
Talk to us today
Insights
Services
Services
Mergermarket
Debtwire
Dealogic
Infralogic
Blackpeak
Backstop
Events
About Us
Contact Us
Explore our latest insights
- All Regions -
North America
Europe
APAC
Latin America
Middle East & Africa
All Regions
consumer retail
Business Services
Communications
Consumer & Retail
Construction
Energy & Natural Resources
Financial Services
Government
Healthcare
Industrials
Media & Entertainment
Pharmaceuticals
Real Estate
Technology
Transportation
ipos
ECM
CLO
Funds
Infrastructure
IPOs
LBOs
M&A
New Issuance (DCM & Loans)
Private Credit
Private Equity
Project Finance
Regulatory
Restructuring
Risk and Compliance
Stressed and Distressed
Structured Finance
- All Content Types -
Data Insight
Interview
League Table
News (Intelligence)
Report
Press Release
Podcast
Video
View all
Data Insight
News (Intelligence)
Interview
Report
League Table
Podcast
Press Release
Charts of the week
All Content
dealogic
AVCJ
Uncategory
Blackpeak Home Page
Creditflux
Mergermarket
Debtwire
Dealogic
Infralogic
Latest News
Data Insight
Spring shoots: early listings boost DACH IPO market
10th May 2024
News (Intelligence)
Quixotic no more: Puig’s listing could spark IPO wave in Spain
19th April 2024
News (Intelligence)
Luxury Premium: Puig to test investor price sensitivity over best IPO assets
15th April 2024
News (Intelligence)
Be big or be different: Puig and CVC are top IPO draw, but select small listings can still find an audience
8th April 2024
A tale of two deals: Galderma and Douglas opposite fates clouds packed post-Easter IPO window
25th March 2024
10th May 2024
Spring shoots: early listings boost DACH IPO market
Data Insight
19th April 2024
Quixotic no more: Puig’s listing could spark IPO wave in Spain
News (Intelligence)
15th April 2024
Luxury Premium: Puig to test investor price sensitivity over best IPO assets
News (Intelligence)
8th April 2024
Be big or be different: Puig and CVC are top IPO draw, but select small listings can still find an audience
News (Intelligence)
25th March 2024
A tale of two deals: Galderma and Douglas opposite fates clouds packed post-Easter IPO window
4th March 2024
Away we go: Galderma to follow Douglas off IPO start line in packed calendar until summer
Load More